A146 ASSESSMENT OF THE USE OF THERAPEUTIC DRUG MONITORING OF INFLIXIMAB DURING MAINTENANCE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE

BACKGROUND: Infliximab (IFX) was proven effective in the induction and maintenance of remission in inflammatory bowel diseases (IBD) in both children and adults. There is a significant number of individual who lose response to the medication. Measurable IFX drug levels correlate with clinical respon...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Can Assoc Gastroenterol
Hlavní autoři: Chavannes, M, Gervais, F, Robitaille, R, Marchand, V, Deslandres, C, Jantchou, P
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Poster Presentations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507680/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.147
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky